Lilly Blocked From Selling Boehringer's Tradjenta Until At Least May 31

Judge says Lilly would be sharing confidential Amylin data by having its Byetta sales reps promote Tradjenta; Lilly plans to increase its diabetes sales force from 774 to 1,144.

More from Archive

More from Pink Sheet